Attention & ADD/ADHD
Large study finds positive yet mixed results from Akili’s digital therapeutic for kids with ADHD
__ Full publication of pivotal trial data outlines Akili’s case for FDA regulation (MobiHealthNews): “A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending…
Read MoreStudy finds combined pharma + non-pharma treatment most beneficial to help youth with ADHD address long-term academic difficulties
__ Academic difficulties are one of the most important adverse consequences of ADHD, and they frequently contribute to parents’ decision to seek treatment for their child. Whether treatment consistently yields a positive impact on long-term academic success is thus an important issue; however, the answer to this question has been somewhat controversial.
Read MoreWill digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?
___ Akili Interactive: Digital pediatric ADHD therapeutic performs well with or without accompanying stimulant therapy (MobiHealth News): “Digital therapeutic company Akili Interactive has announced the first results of an open-label, multisite pediatric ADHD trial providing some patients with the company’s video game-like treatment alongside a stimulant medication. According to the company, both those who received…
Read MoreStudy: Having ADHD costs $1.1 million in lower lifetime earnings, even when “treated”
Relatively few studies have examined the impact of childhood ADHD on long-term financial outcomes, even though becoming self-supporting and attaining financial independence is an important developmental task. An especially comprehensive look at this issue is provided in a study by Pelham et al published recently in the Journal of Consulting and Clinical Psychology. The Study: Participants…
Read MoreFDA clears Trigeminal nerve stimulation (TNS) as ADHD treatment
_____ Although stimulant medications are generally considered to be a safe and effective treatment for ADHD, not all children benefit from this approach. Many parents are reluctant to begin their child on medication and some children experience unacceptable side affects. For these reasons, developing safe and effective alternative treatments for ADHD remains a priority. Trigeminal…
Read MoreLack of sleep seen to cause sluggish cognitive tempo (SCT) in adolescents with attention deficits
___ It is estimated that up to 75% of youth with ADHD have sleep problems. And, experimental studies that manipulate sleep quantity have demonstrated a causal link between sleep and ADHD behavior in children. However, there has been no prior work in which sleep duration has been manipulated in adolescents diagnosed with ADHD.
Read More